Main Article Content


Background: Hemophilia can cause musculoskeletal complications and decreased bone density is one of those complications. The profile of hemophilic patients with decreased bone density in Indonesia is still unknown.

Objective: To estimate the proportion of decreased bone density hemophilia and to learn the characteristics of hemophilic patients with decreased bone density.

Methods: This is a cross-sectional study done in June - November 2012. Subjects were adult hemophilic patients from 19-50 years old in Hematology- Oncology outpatient clinic Cipto Mangunkusumo Hospital. Estimated variables were bone density mass, age, body
mass index, physical activity, arthropathy, substitution therapy, HIV, and HCV infection.

Result: 63 subjects were included in the study with median age of 26 years old. The proportion of decreased bone density in hemophilia was 6.3%. Subjects with decreased bone density were younger (19 years old vs 26 years old), have lower BMI (18,6 + 2,8 kg/m2 vs 21,5 + 3,8 kg/m2), used more substitution therapy (4047 IU/month vs 2000 IU/month), and have better clinical arthropathy score. HCV infection happened on 25% subjects with decreased bone density while HIV was on 1.6% of subjects.

Conclusion: Decreased bone density was found in 6.3% of subjects with hemophilia. They were younger, have lower BMI, better joint score, lower infection caused by transfusion, and more bleeding compared with subjects with normal bone density.

Article Details

How to Cite
Anggoro, S., Setyohadi, B., Sukrisman, L., & Setiati, S. (2018). The characteristics of hemophilic patients with decreased bone density in Cipto Mangunkusumo Hospital Jakarta. Indonesian Journal of Rheumatology, 4(1).


  1. World Federation of Hemophilia.Guidelines for the management of hemophilia. 2nd ed. 2012, Montreal: World Federation of Hemophilia.
  2. World Federation of Hemophilia.Report on the annual global survey 2009. 2011, Montreal: World Federation of Hemophilia.
  3. Rodriguez-Merchan E. Musculoskeletal complications of hemophilia. HSSJ. 2010; 6: p. 37-42.
  4. WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and management of osteoporosis. WHO technical report series. 2003, Geneva: World Health Organization.
  5. Lane NE. Metabolic bone disease, in: Kelley’s textbook of rheumatology. Firestein G, Budd R, Jr EH, McInnes B, Ruddy S and Sergent J, Editors. W. B. Saunders Company: Philadelphia;2008.
  6. International Osteoporosis Foundation.Facts and statistics about osteoporosis and its impact[internet].2010[disitasi 12 Mei 2012]. Tersedia di:
  7. Gallacher S, Deighan C, Wallace A, Cowan R, Fraser W, Fenner J, et al. Association of severe hemophilia A with osteoporosis: A densitometric and biochemical study. Q J Med. 1994; 87: p. 181-6.
  8. Barnes C, Wong P, Egan B, Speller T, Cameron F, Jones G, et al. Reduced bone density among children with severe hemophilia. Pediatrics. 2004;114: p. e177-81.
  9. Wallny T, Scholz D, Oldenburg J, Nicolay C, Ezziddin S, Pennekamp P, et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia. 2007; 13: p. 79-84.
  10. . Nair A, Jijina F, Ghosh K, Madkaikar M, Shrikhande M,Nema M. Osteoporosis in young haemophiliacs from Western India. Am J Hematol. 2007; 82: p. 453-7.
  11. . Iorio A, Fabricciani G, Marcucci M, Brozzetti M,Filipponi P. Bone mineral density in haemophilia patients: A meta-analysis. Thromb Haemost. 2010; 103: p. 596-603.
  12. . Abdelrazik N, Reda M, El-Ziny M,Rabea H. Evaluation of bone mineral
  13. density in children with hemophilia: Mansoura University Children Hospital (MUCH) experience, Mansoura, Egypt. Hematol. 2007; 12(5):p. 431-7.
  14. . Tlacuillo-Parra A, Morales-Zambrano R, Tostado-Rabago N, EsparzaFlores M, Lopez-Guido B,Orozco-Alcala J. Inactivity is a risk factor for low bone mineral density among haemophilic children. Br J Haematol. 2008;140: p. 562-7.
  15. . Mansouritorghabeh H, Rezaieyazdi Z,Badiei Z. Are individuals with severe haemophilia A prone to reduced bone density? Rheumatol Int. 2008; 28: p. 1079-83.
  16. . Tencer T, Friedman H, Li-Mcleod J,Johnson K. Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection. J Manag Care Pharm. 2007; 13(9): p. 790-8.
  17. . Carlsson K, Hojgard S, Lindgren A, Lethagen S, Schulman S, Glomstein A, et al. Costs of on-demand and prophylactic treatment for sever haemophilia in Norway and Sweden. Haemophilia. 2004; 10: p. 515-26.
  18. . Valentino LA, Pipe SW, Tarantino MD, Ye X, Xiong Y,Luo MP. Healthcare resource utilization among haemophilia A patients in the United States. Haemophilia. 2012; 18: p. 332-8.
  19. . Gerstner G, Damiano M, Tom A, Worman C, Schultz W, Recht M, et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia. 2009; 15: p. 559-65.
  20. . Khawaji M, Akesson K,Berntorp E. Long term prophylaxis in severe haemophilia seems to preserve bone mineral density. Haemophilia. 2009; 15: p. 261-6.
  21. . Katsarou O, Terpos E, Chatzimalis P, Provelengios S, Adraktas T, Hadjidakis D, et al. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: Correlations with hemophilic arthropathy and HIV infection. Ann Hematol. 2010; 89: p. 67-74.
  22. . Khawaji M, Astermark J, Akesson K,Berntorp E. Physical activity for prevention of osteoporosis in patients with severe haemophilia on longterm prophylaxis. Haemophilia. 2010; 16: p. 495-501.
  23. . Mansouritorghabeh H, Rezaieyazdi Z, Saadati N, Saghafi M, Mirfeizi Z,Rezai J. Reduced bone density in individuals with severe hemophilia B. Int J Rheum Dis. 2009; 12: p. 125-9.
  24. . Christoforidis A, Economou M, Papadopoulou E, Kazantzidou E, GompakisN,Athanassiou-Metaxa M. Bone status of children with hemophilia A assessed with quantitative ultrasound sonography (QUS) and dualenergy x-ray absorptiometry (DXA). J Pediatr Hematol Oncol. 2010; 32:p. e259-63.
  25. . Tlacuilo-Parra A, Villela-Rodriguez J, Garibaldi-Covarrubias R, Soto-Padilla J,Orozco-Alcala J. Bone turnover markers and bone mineral density in children with haemophilia. Haemophilia. 2011; 17: p. 657-61.
  26. . Ranta S, Viljakainen H, Makipernaa A,Makitie O. Hypercalciuria in children with haemophilia suggests primary skeletal pathology. Br J Haematol.2011; 153(5): p. 364-71.
  27. . Rezaeifarid M, Soveid M, Ghaemi S,Karimi M. Bone mineral density in Iranian patients with haemophilia: The first experience in southern iran. Haemophilia. 2011; 17(3): p. 552-3.
  28. . Roosendaal G, Vianen ME, Wenting MJG, Rinsum ACv, Berg HMvd, Lafeber FPJG, et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg. 1998; 80-B: p.540-4.
  29. . Schiefke I, Fach A, Wiedmann M, Aretin A, Schenker E, Borte G, et al.Reduced bone mineral density and altered bone turnover markers inpatients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol. 2005; 11(12): p. 1843-7.
  30. . Malham M, Jorgensen S, Ott P, Agnholt J, Vilstrup H, Borre M, et al. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J Gastroenterol. 2011; 17(7): p. 922-5.
  31. . Perrini S, Laviola L, Carreira M, Cignarelli A, Natalicchio A,Giorgino F. The GH/IGF1 axis and signaling pathways in the muscle and bone: Mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol. 2010; 205: p. 201-10.
  32. . George J, Ganesh H, Acharya S, Bandgar T, Shivane V, Karvat A, et al. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol. 2009; 15(28): p. 3516-22.
  33. . Gurevitch O,Slavin S. The hematological etiology of osteoporosis. Med Hypotheses. 2006; 67: p. 729-35.
  34. . Gurevitch O, Khitrin S, Valitov A,Slavin S. Osteoporosis of hematologic etiology. Exp Hematol. 2007; 35: p. 128-36.
  35. . Baud’huin M, Duplomb L, Teletchea S, Charrier C, Maillasson M, Fouassier M, et al. Factor viii-Von Willebrand factor complex inhibits osteoclastogenesis and control cell survival. J Biol Chem. 2009; 284(46): p. 31704-13.
  36. . Liel MS, Greenberg DL, Recht M, Vanek C, Klein RF,Taylor JA. Decreasebone density and bone strength in a mouse model of severe factor viii deficiency. Br J Haematol. 2012; 158: p. 138-52.
  37. . Christoforidis A, Economou M, Papadopoulou E, Kazantzidou E, Farmaki E,Tzimouli V, et al. Comparative study of dual energy x-ray absorptiometryand quantitative ultrasonography with the use of biochemical markers ofbone turnover in boys with haemophilia. Haemophilia. 2011; 17: p. e217-22.
  38. . Linari S, Montorzi G, Bartolozzi D, Borderi M, Melchiorre D, Benelli M, et al. Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: A study in HCV/HIV or HCV infected patients. Haemophilia.2012(Jul): p. 1-8.
  39. . Naderi A, Nikvarz M, Arasteh M,Shokoohi M. Osteoporosis/osteopenia and hemophilic arthropathy in severe hemophilic patients.Arch Iran Med.2012;15(2): p.82-4.
  40. . Khawaji M, Astermark J, Mackensen SV, Akesson K,Berntorp E. Bonedensity and health-related quality of life in adult patients with severe haemophilia. Haemophilia. 2011; 17: p. 304–11.
  41. . Stonebraker JS, Brooker M, Amand RE, Farrugia A,Srivastava A. A study of reported factor viii use around the world. Haemophilia. 2010; 16: p.33–46.
  42. . Liou WS, Tu TC, Cheng SN, Chou TY, Lee CF, Lin TK, et al. Secondary prophylaxis treatment versus on-demand treatment for patients with severe haemophilia a: Comparisons of cost and outcomes in taiwan. Haemophilia. 2011; 17: p. 45–54.
  43. . Eshghi P, Mahdavi-Mazdeh M, Karimi M,Aghighi M. Haemophilia in the developing countries: The Iranian experience. Arch Med Sci. 2010; 6(1): p. 83-9.
  44. . Schramm W, Gringeri A, Ljung R, Berger K, Crispin A, Bullinger M, et al. Haemophilia care in Europe: The ESCHQOL study. Haemophilia. 2012(18):p. 729-37.
  45. . Kovacs CS. Hemophilia, low bone mass, and osteopenia/osteoporosis. Transfus Apher Sci. 2008; 38: p. 33-40.
  46. . Johnell O, Borgstrom F, Jonsson B,Kanis J. Latitude, socioeconomic prosperity, mobile phones and hip fracture risk. Osteoporos Int. 2007; 18:p. 333-7.
  47. . Anagnostis P, Vakalopoulou S, Slavakis A, Charizopoulou M, Kazantzidou E, Chrysopoulou T, et al. Reduced bone density in patients with haemophilia A and B in Northern Greece. Thromb Haemost. 2012; 107: p. 545-51.
  48. . Lin JC, Hsieh TY, Wu CC, Chen PJ, Chueh TH, Chang WK, et al. Associationbetween chronic hepatitis C virus infection and bone mineral density. Calcif Tissue Int. 2012; 91: p. 423-9.
  49. . Gowda M, Massey G, Kumar AR, Khan A, Nolte M, Kuhn J. Vitamin D deficiency in children with haemophilia. Haemophilia. 2009(15): p. 634-6.